// App-Quantinova.ai

TCTAP A-048 : Outcome of Everolimus Eluting Bioabsorbable Vascular Scaffold(BVS) Compared to Non BVS Drug Eluting Stent in the Management of ST-Segment Elevation Myocardial Infarction(STEMI) - A Comparative Study

Researchers

Presenter

  • Soumya Patra

Principal Investigators

  • Rabindranath Chakraborty

  • Praskas Chandra Mandal

Medical Centers

  • Apollo Gleneagles Hospital, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved